DGAP-News: ENCAVIS AG has been promoted to the STOXX Europe 600
2022. szeptember 05., hétfő, 07:00
2022/09/05 Corporate News ENCAVIS has been promoted to the STOXX Europe 600 Hamburg, September 5, 2022 – The Hamburg-based wind and solar park operator Encavis AG (Prime Standard; ISIN: DE0006095003, stock symbol: ECV), which is listed on the MDAX of Deutsche Börse AG, has been promoted to the STOXX Europe 600. “We are very pleased that we, as an independent power producer (IPP) with our continuously growing portfolio of wind and solar parks in Europe, have now been included in the group of the 600 largest European companies”, welcomes Dr Christoph Husmann, CFO of Encavis AG, the promotion to the European index league and adds: “This strengthens the group of renewable energy companies in the STOXX 600.” This index change primarily affects exchange-traded funds that replicate stock indices in real terms (especially physically replicating ETFs), because these funds have to rebalance and reweight their stocks according to the new weighting, which can lead to an increased trading volume of the respective stocks. The index adjustments of the STOXX Europe 600 will be implemented at the beginning of trading on Monday, September 19, 2022. About ENCAVIS: Additional information can be found on www.encavis.com www.encavis.com
|
Language: | English |
Company: | ENCAVIS AG |
Große Elbstraße 59 | |
22767 Hamburg | |
Germany | |
Phone: | +49 4037 85 62 -0 |
Fax: | +49 4037 85 62 -129 |
E-mail: | [email protected] |
Internet: | https://www.encavis.com |
ISIN: | DE0006095003 |
WKN: | 609500 |
Indices: | MDAX |
Listed: | Regulated Market in Frankfurt (Prime Standard), Hamburg; Regulated Unofficial Market in Berlin, Dusseldorf, Munich, Stuttgart, Tradegate Exchange |
EQS News ID: | 1434665 |
End of News | DGAP News Service |
1434665 05.09.2022 CET/CEST
Közzétételek - archívum
-
» Laxxon Medical to Participate in the BIO CEO & Investor Conference
[2023.02.02. 20:15]
-
» PJSC Magnitogorsk Iron and Steel Works: MMK notifies on additional extension of consent solicitation process
[2022.06.30. 13:00]
-
» Evonik Industries and Laxxon Medical see future in 3D screen printed pharmaceuticals
[2022.03.08. 15:02]
-
» Evonik und Laxxon Medical sehen Zukunftsmarkt für 3D-Druck von Tabletten
[2022.03.08. 15:02]
-
» "Game Changing" Technology Enables QR Code Integration with 3D Screen Printing
[2022.02.16. 17:31]
-
» Laxxon Medical to Participate in the 24th Annual Needham Virtual Growth Conference
[2022.01.07. 16:40]
-
» EQS-News: Focus Financial Partners Announces the Launch of Beryllus Capital in a Leading-Edge Joint Venture with the Hinduja Group
[2021.03.22. 12:45]
-
» DGAP-Adhoc: TRATON SE: TRATON und Navistar einig über Fortsetzung der Gespräche
[2020.10.16. 18:43]
-
» DGAP-Adhoc: TRATON SE: TRATON and Navistar agreement in principle
[2020.10.16. 18:43]